Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Oncotargets and Therapy
|
September 18, 2013
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
Heather M Shaw, Marcia Hall
Expert Review of Anticancer Therapy
|
April 27, 2013
Vemurafenib in melanoma
Heather M Shaw, Paul D Nathan
Melanoma Research
|
November 6, 2018
Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis
Romaana Mir, Heather M Shaw, Paul D Nathan
Therapeutic Advances in Medical Oncology
|
March 27, 2023
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
Sarah Howlett, Thomas J Carter, Heather M Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
Karla A Lee, Heather M Shaw, Veronique Bataille, et al.
Molecular Biology of the Cell
|
June 11, 2010
The retinoblastoma protein modulates Tbx2 functional specificity
Keith W Vance, Heather M Shaw, Mercedes Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2009
A first-in-man phase i and pharmacokinetic study on CHR-2797 (Tosedostat), an inhibitor of M1 aminopeptidases, in patients with advanced solid tumors
Alison H M Reid, Andrew Protheroe, Gerhardt Attard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors
Paul Haluska, Heather M Shaw, Gretchen N Batzel, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion
Suzanah C Boyd, Branka Mijatov, Gulietta M Pupo, et al.
Ebiomedicine
|
August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
Niccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Oncotargets and Therapy
|
September 18, 2013
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib
Heather M Shaw, Marcia Hall
Expert Review of Anticancer Therapy
|
April 27, 2013
Vemurafenib in melanoma
Heather M Shaw, Paul D Nathan
Melanoma Research
|
November 6, 2018
Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis
Romaana Mir, Heather M Shaw, Paul D Nathan
Therapeutic Advances in Medical Oncology
|
March 27, 2023
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
Sarah Howlett, Thomas J Carter, Heather M Shaw, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2020
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications
Karla A Lee, Heather M Shaw, Veronique Bataille, et al.
Molecular Biology of the Cell
|
June 11, 2010
The retinoblastoma protein modulates Tbx2 functional specificity
Keith W Vance, Heather M Shaw, Mercedes Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2009
A first-in-man phase i and pharmacokinetic study on CHR-2797 (Tosedostat), an inhibitor of M1 aminopeptidases, in patients with advanced solid tumors
Alison H M Reid, Andrew Protheroe, Gerhardt Attard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors
Paul Haluska, Heather M Shaw, Gretchen N Batzel, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion
Suzanah C Boyd, Branka Mijatov, Gulietta M Pupo, et al.
Ebiomedicine
|
August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
Niccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
Page
of 2